Damien McDevitt, Chief Executive Officer at AKCEA THERAPEUTICS, INC. (AKCA), sold 18,834 shares at $11.75 ($221K) on 2020-03-23, disclosed to the SEC on 2020-03-25.
Open-market sale of $221k AKCA by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.75 | 9,417 | $111K | 50.0% |
| 2 | $11.75 | 9,417 | $111K | 50.0% |
| Total | $11.75 avg | 18,834 | $221K | 100% |